Newly Defined Cancer Driver is Fast, Furious and Loud
Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.
June 26, 2019 2:00 PM
Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
New Way to Predict Complications After Larynx Cancer Surgery
When the surgical wound doesn’t heal right, it can send some patients back to the operating room.
May 30, 2019 4:02 PM
Researchers Find New Target to Improve Response to Cancer Immunotherapy
A U-M study is the first to define how a little-known type of cell death impacts tumor cells and immune cells.
May 01, 2019 1:00 PM
Study: Therapy Completely Clears HPV in One-Third of Cervical Precancers
Clinical trial shows promise of immune treatment against HPV infections that lead to cancer
April 03, 2019 2:34 PM
A Protein’s Surprising Role Offers Clues to Limit Graft-vs.-Host Disease
While it plays a protective role in other diseases, knocking out NLRP6 in mice led to better outcomes, less-severe symptoms after bone marrow transplant.
March 22, 2019 8:24 AM
Attacking ‘Invisible Threat’ that Affects Cancer Care Workers
Exposure to chemotherapy can create hazards for nurses, pharmacists as they deliver lifesaving care to patients, but use of protective devices remains low.<
March 01, 2019 11:35 AM
